Matthias Bodenstedt Moon Lake Immunotherapeutics (MLTX) insider trading activity
Matthias Bodenstedt is Chief Financial Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 1.28 Million shares of MLTX, which is worth approximately $16.3 Million. The most recent transaction as insider was on Jan 07, 2026, when has been sold 354,296 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.28M
103.38%
3M change
145.02%
12M change
Total Value Held
$16.3 Million
Matthias Bodenstedt Transaction History
MB
Matthias Bodenstedt
Chief Financial Officer
Zug, V8